aveni(R) S.A. Raises EUR 8.9M ($10.5M) in Series B Financing from Merck Ventures and Existing Investors to Commercialize its Innovative Metallization Technologies
PARIS, FRANCE — (Marketwired) — 10/24/17 — aveni S.A., developer and manufacturer of market disrupting wet deposition technologies and chemistries for 2D interconnects and 3D TSV packaging, today announced it has completed a EUR 8.9M ($10.5M) capital raise from Merck Ventures, the corporate venture arm of Merck, along with existing investors."This new investment by corporate venture capital funds of leading science and technology players like Merck, with their specific expertise, among